Idioma:

Supplemental Material, sj-jpg-4-rep-10.1177_25158163221131326 - Eptinezumab administered intravenously, subcutaneously, or intramuscularly in healthy subjects and/or patients with migraine: Early development studies

Baker, Brian ; Shen, Vivienne ; Cady, Roger ; Ettrup, Anders ; Larsen, Frank

Texto completo disponível

Citações Citado por

Título:
Supplemental Material, sj-jpg-4-rep-10.1177_25158163221131326 - Eptinezumab administered intravenously, subcutaneously, or intramuscularly in healthy subjects and/or patients with migraine: Early development studies
Autor: Baker, Brian ; Shen, Vivienne ; Cady, Roger ; Ettrup, Anders ; Larsen, Frank
Assuntos: FOS: Clinical medicine ; Neurology and Neuromuscular Diseases
Notas: 10.1177/25158163221131326
RelationTypeNote: IsSupplementTo -- 10.1177/25158163221131326
Descrição: Supplemental Material, sj-jpg-4-rep-10.1177_25158163221131326 for Eptinezumab administered intravenously, subcutaneously, or intramuscularly in healthy subjects and/or patients with migraine: Early development studies by Brian Baker, Vivienne Shen, Roger Cady, Anders Ettrup and Frank Larsen in Cephalalgia Reports
Editor: SAGE Journals
Data de criação/publicação: 2022
Idioma: Inglês

Links

Voltar para lista de resultados